Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00821067 · ClinicalTrials.gov registry record · NA

The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study

A NA study of Fatigue, sponsored by Bioenergy Life Science.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT00821067: Completed NA study of Fatigue, sponsored by Bioenergy Life Science.

NCT00821067 is a NA study of Fatigue that has completed, run by Bioenergy Life Science. The registered enrollment target is 40 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00821067, a NA study of Fatigue, has completed, sponsored by Bioenergy Life Science.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

D-ribose, a natural occurring pentose carbohydrate, has repeatedly shown to enhance high-energy phosphates and improve function following ischemia, states of congestive heart failure, and recently in subjects with lung disease. An initial preliminary, open label pilot study demonstrated a positive benefit of D-ribose in "Baby-Boomer" subjects aged 50 to 65 years old complaining of persistent fatigue. The objective of this study will build on the previously collected data to evaluate oral D-ribose vs. dextrose (administered as a supplement) in relatively healthy, yet fatigued subjects with a goal of improving their state of fatigue.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT D-ribose
  • DIETARY_SUPPLEMENT Dextrose

Study Locations (1)

Colorado

  • Aurora Denver Cardiology Association - Denver

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-01
Est. Completion 2009-05
Phase NA
Bioenergy Life Science

1 total trials

What the finished NCT00821067 record still lists

NCT00821067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Fatigue appearing as the primary indexed condition, and to 2 interventions - of which D-ribose is the first listed.

NCT00821067 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT00821067 about?

NCT00821067 is a clinical study titled "The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study". D-ribose, a natural occurring pentose carbohydrate, has repeatedly shown to enhance high-energy phosphates and improve function following ischemia, states of congestive heart failure, and recently in subjects with lung disease. An initial preliminary, open label pilot study demonstrated a positive b...

What is the current status of trial NCT00821067?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-01. Estimated completion is 2009-05.

What conditions does trial NCT00821067 study?

This clinical trial studies the following conditions: Fatigue.

What interventions are being tested in trial NCT00821067?

The interventions under investigation include: D-ribose (DIETARY_SUPPLEMENT), Dextrose (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00821067?

This trial is sponsored by Bioenergy Life Science, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00821067 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatigue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00821067's enrollment target sits among peer trials

40 71st of 109 higher than 35 of 109 other Fatigue trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00821067, the US trial registry maintained by the National Library of Medicine. NCT00821067 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.